MyGenomeBox enters K-OTC market... Trading starts from the 15th

[Asia Economy Reporter Kum Boryeong] Starting from the 15th, shares of 'MyGenomeBox' will be available for trading on the K-OTC market.

The Korea Financial Investment Association announced on the 11th that it has approved the new registration of MyGenomeBox on the K-OTC market.

Founded in 2015, MyGenomeBox is a small venture company that provides services enabling individuals to understand and utilize their genomic information through DNA applications. Recently, it obtained cloud personal information and computing security certification. Going forward, it plans to build a MyData platform based on genomic data.

As of December 31st last year, MyGenomeBox reported total assets of 3.912 billion KRW, total liabilities of 2.372 billion KRW, total equity of 1.18 billion KRW, and sales revenue of 1.432 billion KRW.

From the 15th, MyGenomeBox shares can be traded through securities firms' Home Trading Systems (HTS) and other platforms. On trading days, shares can be traded within a range of 30% to 500% of the net asset value per share. Thereafter, the price limit will be ±30% of the previous day's weighted average price.

With the approval of MyGenomeBox's new registration, six companies have entered the K-OTC market this year, bringing the total number of companies to 133.

This content was produced with the assistance of AI translation services.